Evaluating the Safety and Tolerability of the Combination of Dabrafenib, Trametinib and Palliative Radiotherapy in Patients with Metastatic BRAF V600E/K Mutation-positive Cutaneous Melanoma

T.W. Wang; J.L. Smith; M. Carlino; B. Burmeister; M.B. Pinkham; G.B. Fogarty; D. Christie; V. Estall; M. Shackleton; R. Wolfe; L.T.P. Thao; E.J. Paton; V. Steel; N.C. Williams

doi:10.1016/j.ijrobp.2020.07.866

Evaluating the Safety and Tolerability of the Combination of Dabrafenib, Trametinib and Palliative Radiotherapy in Patients with Metastatic BRAF V600E/K Mutation-positive Cutaneous Melanoma

T.W. Wang, J.L. Smith, M. Carlino, B. Burmeister, M.B. Pinkham, G.B. Fogarty, D. Christie, V. Estall, M. Shackleton, R. Wolfe, L.T.P. Thao, E.J. Paton, V. Steel, N.C. Williams

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S133-S134
Number of pages	2
Journal	International Journal of Radiation Oncology Biology Physics
Volume	108
Issue number	3 Supplement
DOIs	https://doi.org/10.1016/j.ijrobp.2020.07.866
Publication status	Published - Nov 2020

Access to Document

10.1016/j.ijrobp.2020.07.866

Cite this

Wang, T. W., Smith, J. L., Carlino, M., Burmeister, B., Pinkham, M. B., Fogarty, G. B., Christie, D., Estall, V., Shackleton, M., Wolfe, R., Thao, L. T. P., Paton, E. J., Steel, V., & Williams, N. C. (2020). Evaluating the Safety and Tolerability of the Combination of Dabrafenib, Trametinib and Palliative Radiotherapy in Patients with Metastatic BRAF V600E/K Mutation-positive Cutaneous Melanoma. International Journal of Radiation Oncology Biology Physics, 108(3 Supplement), S133-S134. https://doi.org/10.1016/j.ijrobp.2020.07.866

@article{a18322f3c7da4955a5e46c7deccddab5,

title = "Evaluating the Safety and Tolerability of the Combination of Dabrafenib, Trametinib and Palliative Radiotherapy in Patients with Metastatic BRAF V600E/K Mutation-positive Cutaneous Melanoma",

author = "T.W. Wang and J.L. Smith and M. Carlino and B. Burmeister and M.B. Pinkham and G.B. Fogarty and D. Christie and V. Estall and M. Shackleton and R. Wolfe and L.T.P. Thao and E.J. Paton and V. Steel and N.C. Williams",

note = "Oral Abstract 1036",

year = "2020",

month = nov,

doi = "10.1016/j.ijrobp.2020.07.866",

language = "English",

volume = "108",

pages = "S133--S134",

journal = "International Journal of Radiation Oncology Biology Physics",

issn = "0360-3016",

publisher = "Elsevier",

number = "3 Supplement",

}

Wang, TW, Smith, JL, Carlino, M, Burmeister, B, Pinkham, MB, Fogarty, GB, Christie, D, Estall, V, Shackleton, M , Wolfe, R , Thao, LTP, Paton, EJ, Steel, V & Williams, NC 2020, 'Evaluating the Safety and Tolerability of the Combination of Dabrafenib, Trametinib and Palliative Radiotherapy in Patients with Metastatic BRAF V600E/K Mutation-positive Cutaneous Melanoma', International Journal of Radiation Oncology Biology Physics, vol. 108, no. 3 Supplement, pp. S133-S134. https://doi.org/10.1016/j.ijrobp.2020.07.866

Evaluating the Safety and Tolerability of the Combination of Dabrafenib, Trametinib and Palliative Radiotherapy in Patients with Metastatic BRAF V600E/K Mutation-positive Cutaneous Melanoma. / Wang, T.W.; Smith, J.L.; Carlino, M. et al.
In: International Journal of Radiation Oncology Biology Physics, Vol. 108, No. 3 Supplement, 11.2020, p. S133-S134.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Evaluating the Safety and Tolerability of the Combination of Dabrafenib, Trametinib and Palliative Radiotherapy in Patients with Metastatic BRAF V600E/K Mutation-positive Cutaneous Melanoma

AU - Wang, T.W.

AU - Smith, J.L.

AU - Carlino, M.

AU - Burmeister, B.

AU - Pinkham, M.B.

AU - Fogarty, G.B.

AU - Christie, D.

AU - Estall, V.

AU - Shackleton, M.

AU - Wolfe, R.

AU - Thao, L.T.P.

AU - Paton, E.J.

AU - Steel, V.

AU - Williams, N.C.

N1 - Oral Abstract 1036

PY - 2020/11

Y1 - 2020/11

U2 - 10.1016/j.ijrobp.2020.07.866

DO - 10.1016/j.ijrobp.2020.07.866

M3 - Meeting Abstract

SN - 0360-3016

VL - 108

SP - S133-S134

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

IS - 3 Supplement

ER -

Wang TW, Smith JL, Carlino M, Burmeister B, Pinkham MB, Fogarty GB et al. Evaluating the Safety and Tolerability of the Combination of Dabrafenib, Trametinib and Palliative Radiotherapy in Patients with Metastatic BRAF V600E/K Mutation-positive Cutaneous Melanoma. International Journal of Radiation Oncology Biology Physics. 2020 Nov;108(3 Supplement):S133-S134. doi: 10.1016/j.ijrobp.2020.07.866